Cathay Biotech Statistics

Total Valuation

Cathay Biotech has a market cap or net worth of CNY 29.22 billion. The enterprise value is 29.50 billion.

Market Cap	29.22B
Enterprise Value	29.50B

Important Dates

The next estimated earnings date is Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Jul 24, 2024

Share Statistics

Cathay Biotech has 581.32 million shares outstanding. The number of shares has decreased by -1.00% in one year.

Shares Outstanding	581.32M
Shares Change (YoY)	-1.00%
Shares Change (QoQ)	+1.50%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	16.49%
Float	216.18M

Valuation Ratios

The trailing PE ratio is 78.55.

PE Ratio	78.55
Forward PE	n/a
PS Ratio	11.56
PB Ratio	2.64
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 54.71, with an EV/FCF ratio of -43.03.

EV / Earnings	79.29
EV / Sales	11.67
EV / EBITDA	54.71
EV / EBIT	124.69
EV / FCF	-43.03

Financial Position

The company has a current ratio of 2.78, with a Debt / Equity ratio of 0.09.

Current Ratio	2.78
Quick Ratio	2.09
Debt / Equity	0.09
Debt / EBITDA	2.40
Debt / FCF	-1.91
Interest Coverage	7.89

Financial Efficiency

Return on equity (ROE) is 2.58% and return on invested capital (ROIC) is 0.93%.

Return on Equity (ROE)	2.58%
Return on Assets (ROA)	0.83%
Return on Capital (ROIC)	0.93%
Revenue Per Employee	1.40M
Profits Per Employee	206,385
Employee Count	1,803
Asset Turnover	0.14
Inventory Turnover	1.29

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.83% in the last 52 weeks. The beta is 0.64, so Cathay Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-7.83%
50-Day Moving Average	37.31
200-Day Moving Average	44.58
Relative Strength Index (RSI)	72.38
Average Volume (20 Days)	3,052,558

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cathay Biotech had revenue of CNY 2.53 billion and earned 372.11 million in profits. Earnings per share was 0.64.

Revenue	2.53B
Gross Profit	713.75M
Operating Income	244.45M
Pretax Income	434.96M
Net Income	372.11M
EBITDA	547.09M
EBIT	244.45M
Earnings Per Share (EPS)	0.64

Full Income Statement

Balance Sheet

The company has 4.64 billion in cash and 1.31 billion in debt, giving a net cash position of 3.32 billion or 5.72 per share.

Cash & Cash Equivalents	4.64B
Total Debt	1.31B
Net Cash	3.32B
Net Cash Per Share	5.72
Equity (Book Value)	14.89B
Book Value Per Share	19.01
Working Capital	4.37B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 680.74 million and capital expenditures -1.37 billion, giving a free cash flow of -685.60 million.

Operating Cash Flow	680.74M
Capital Expenditures	-1.37B
Free Cash Flow	-685.60M
FCF Per Share	-1.18

Full Cash Flow Statement

Margins

Gross margin is 28.23%, with operating and profit margins of 9.67% and 14.72%.

Gross Margin	28.23%
Operating Margin	9.67%
Pretax Margin	17.21%
Profit Margin	14.72%
EBITDA Margin	21.64%
EBIT Margin	9.67%
FCF Margin	-27.12%

Dividends & Yields

This stock pays an annual dividend of 0.19, which amounts to a dividend yield of 0.37%.

Dividend Per Share	0.19
Dividend Yield	0.37%
Dividend Growth (YoY)	5.56%
Years of Dividend Growth	n/a
Payout Ratio	37.55%
Buyback Yield	1.00%
Shareholder Yield	1.37%
Earnings Yield	1.27%
FCF Yield	-2.35%

Dividend Details

Stock Splits

The last stock split was on July 20, 2022. It was a forward split with a ratio of 1.4.

Last Split Date	Jul 20, 2022
Split Type	Forward
Split Ratio	1.4

Scores

Cathay Biotech has an Altman Z-Score of 5.93.

Altman Z-Score	5.93
Piotroski F-Score	n/a